Mostrando 10 resultados de: 13
Filtros aplicados
Publisher
British Journal of Clinical Pharmacology(3)
European Journal of Clinical Pharmacology(2)
Therapeutic Drug Monitoring(2)
Clinical Pharmacology and Therapeutics(1)
Clinical neuropharmacology(1)
Área temáticas
Farmacología y terapéutica(10)
Enfermedades(6)
Medicina y salud(3)
Bioquímica(2)
Problemas sociales y servicios a grupos(2)
Objetivos de Desarrollo Sostenible
ODS 17: Alianzas para lograr los objetivos(8)
ODS 10: Reducción de las desigualdades(7)
ODS 12: Producción y consumo responsables(5)
ODS 9: Industria, innovación e infraestructura(5)
ODS 5: Igualdad de género(1)
Origen
scopus(13)
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.
ArticleAbstract: In a previous study we showed that the disposition of clozapine after a single oral dose is unrelatePalabras claves:Autores:Adrián LLerena, Alm C., Benitez Rodriguez J., Bertilsson L., Bondesson U., Carrillo J., Dahl M.L., Lindstrom L., Ramos S., Rodriguez de la Rubia I.Fuentes:scopusAntibiotic use in 3 European university hospitals
ArticleAbstract: The use of antibiotic drugs was studied in university teaching hospitals in Tartu, Estonia, HuddingePalabras claves:Autores:Adrián LLerena, Berecz R., Dahl M.L., Kiivet R.A., Maimets M., Wettermark B.Fuentes:scopusCYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers
ArticleAbstract: Objective: This study analyzed the frequency of CYP2C9 variant alleles and evaluated the impact of CPalabras claves:CYP2C9, Diclofenac, GenotypingAutores:Adrián LLerena, Berecz R., Dahl M.L., Dorado P., Norberto M., Yasar U.Fuentes:scopusAn Appeal to the Global Health Community for a Tripartite Innovation: An "essential Diagnostics List," "health in All Policies," and "see-Through 21<sup>st</sup> Century Science and Ethics"
ReviewAbstract: Diagnostics spanning a wide range of new biotechnologies, including proteomics, metabolomics, and naPalabras claves:Autores:Adrián LLerena, Barlas Ö., Birch K., Boehme C., Borda-Rodriguez A., Byne W.M., Chaverneff F., Coşkun Y., Dahl M.L., Dereli T., Diwakar S., Dove E.S., Elbeyli L., Endrenyi L., Eroʇlu-Kesim B., Ferguson L.R., Güngör K., Gürsoy U.K., Hekim N., Huzair F., Kaushik K., Kickbusch I., Klroʇlu O., Kolker E., Könönen E., Lin B., Malhan F., Nair B., Özdemir V., Patrinos G.P., Sardaş S., Sert Ö., Srivastava S., Steuten L.M.G., Toraman C., Vayena E., Wang W., Warnich L.Fuentes:scopusDisposition of clozapine in man: lack of association with debrisoquine and S‐mephenytoin hydroxylation polymorphisms.
ArticleAbstract: A large interindividual variability has previously been demonstrated in the bioavailability, steady‐Palabras claves:Autores:Adrián LLerena, Bertilsson L., Bondesson U., Dahl M.L., Lindstrom L.Fuentes:scopusDisposition of the neuroleptics perphenazine, zuclopenthixol, and haloperidol cosegregates with polymorphic debrisoquine hydroxylation.
ReviewAbstract:Palabras claves:Autores:Adrián LLerena, Bertilsson L., Dahl M.L., Ekqvist B.Fuentes:scopusGenetic factors in the metabolism of haloperidol.
ArticleAbstract:Palabras claves:Autores:Adrián LLerena, Bertilsson L., Dahl M.L., Ekqvist B.Fuentes:scopusHaloperidol disposition is dependent on debrisoquine hydroxylation phenotype
ArticleAbstract: To investigate the importance of genetic factors for the regulation of haloperidol metabolism, we stPalabras claves:debrisoquine, Haloperidol, humans, pharmacogeneticsAutores:Adrián LLerena, Alm C., Bertilsson L., Dahl M.L., Ekqvist B.Fuentes:scopusHaloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: Increased plasma levels of the reduced metabolite in poor metabolizers
ArticleAbstract: We have previously shown that the disposition of haloperidol is decreased in poor (PM) compared to ePalabras claves:debrisoquine, humans, pharmacogenetics, Reduced haloperidolAutores:Adrián LLerena, Bertilsson L., Dahl M.L., Ekqvist B.Fuentes:scopusPatterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden.
ArticleAbstract: 1. Patterns of drug treatment and the use of polypharmacy in schizophrenic in‐patients were comparedPalabras claves:Autores:Adrián LLerena, Dahl M.L., Eklundh T., Kiivet R.A., Rootslane L., Sanchez Vega J., Sjoqvist F.Fuentes:scopus